Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)
Funding Opportunity RFA-DK-23-011 from the NIH Guide for Grants and Contracts. Sodium-glucose co-transporter-2 inhibitors (SGLT2i) that were developed for the treatment of type 2 diabetes (T2D) have significant protective effects for cardiac and renal diseases for people with and without diabetes. However, SGLT2i are not currently approved for individuals with type 1 diabetes (T1D) and there is an increased risk of diabetic ketoacidosis (DKA) for this population. Despite this concern, these drugs are increasingly being prescribed off-label for people with T1D. Continuous ketone monitoring (CKM) is a rapidly evolving tec...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 30, 2024 Category: Research Source Type: funding
Going For Gold and Beyond in the Rural Midwest: Grant for Health Care Organizations
Grants for rural healthcare organizations in the Midwest to lead evidence-based policy and practice changes in the areas of blood pressure, cholesterol, and type 2 diabetes. Geographic coverage: The Midwest region of the American Heart Association -- American Heart Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 16, 2023 Category: American Health Source Type: funding
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
Funding Opportunity RFA-DK-23-021 from the NIH Guide for Grants and Contracts. Cardiovascular complications are the leading cause of death for individuals with type 1 diabetes (T1D) and significantly shorten their lives. Cardiovascular disease (CVD) progression in people with T1D differs from that observed in people with type 2 diabetes (T2D) and residual increased risk of CVD remains after treatment of standard risk factors, such as hyperglycemia, hypertension, and hyperlipidemia. The NIH Cardiovascular Repository for T1D (CaRe-T1D) was initiated with the goal of establishing a biorepository of human CV tissue and a sc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 30, 2023 Category: Research Source Type: funding
Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-25-002 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites cooperative agreement applications to expand the operational scope of the existing Human Pancreas Analysis Program (HPAP) to the study of pancreata recovered from tissue donors with Type 2 Diabetes (T2D) and related metabolic disorders. This NOFO will support one team of investigators with combined expertise in human pancreas physiology and pathophysiology; collection, processing and multimodal analysis of human pancreatic tissues; and biological database building, curation and management, tha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 24, 2023 Category: Research Source Type: funding
Integration of Novel Measures for Improved Classification of Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-23-020 from the NIH Guide for Grants and Contracts. This NOFO invites applications for a Biostatistics Research Center to participate in ?a? ?consortium aimed at improving understanding of heterogeneity of type 2 diabetes (T2D). A separate NOFO (RFA-DK-23-019) will bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals T2D and developing more precise definitions of disease. The ultimate goal of this effort will be to 1) develop a broadly applicable framework for identifying s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2023 Category: Research Source Type: funding
Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed)
Funding Opportunity RFA-DK-23-019 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to create a consortium to bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals with type 2 diabetes (T2D) and developing more precise definitions of disease. The ultimate goal of this effort will be to 1) develop a broadly applicable framework for identifying subtypes of T2D; and 2) increase understanding ofthe physiologic drivers of T2D subtypes to guide development of more effective precision ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2023 Category: Research Source Type: funding
Notice of Special Interest: Administrative Supplements to Support Collaborations to Improve Data Interoperability/Re-use for Existing Type 2 Diabetes Relevant Data Sets
Notice NOT-DK-23-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 30, 2023 Category: Research Source Type: funding
A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes
Funding for evidence-based interventions to decrease risk for type 2 diabetes among adults with prediabetes and improve self-care practices, quality of care, and early detection of complications among people with diabetes. Geographic coverage: Nationwide -- Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - January 18, 2023 Category: American Health Source Type: funding
Mississippi Diabetes Self-Management Education Support Subgrant
Grants to provide training and capacity development to allow organizations in Mississippi to be recognized and certified by the American Diabetes Association (ADA) and the Association of Diabetes Care and Education Specialists (ADCES). The program purpose is to reduce health inequity in areas with limited or no access to evidence ‐based diabetes education, which include rural communities without a recognized or accredited Diabetes Self‐Management Education and Support (DSMES) program and populations that experience high rates of Type 2 diabetes, its complications, and diabetes‐related deaths. Geographic coverage: Mis...
Source: Funding opportunities via the Rural Health Information Hub - October 20, 2022 Category: American Health Source Type: funding
Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for RFA-DK-22-001 Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)
Notice NOT-DK-22-023 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2022 Category: Research Source Type: funding
Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-001 from the NIH Guide for Grants and Contracts. This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 2 diabetes research (SEIC-T2D). A primary goal of the SEIC-T2D is to accelerate equitable engagement of diverse stakeholders in T2D research, particularly those from diverse communities that experience diabetes-related health disparities, and systems that impact their health. The SEIC-T2D will provide highly s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 10, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C Clinical Trial Not Allowed).
Notice NOT-DK-22-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2022 Category: Research Source Type: funding
National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
Funding Opportunity RFA-DK-21-019 from the NIH Guide for Grants and Contracts. The purpose of the Development Of Physician Scientists in Diabetes research (Diabetes-DOCS) Program is to support the career development of physicians committed to a career in diabetes research. The Diabetes-DOCS program is intended to remedy the dearth of pediatric endocrinologists and physicians from other specialties conducting outstanding, innovative research into the causes and consequences of diabetes. Diabetes-DOCS will be a single national program, implemented by one or more PD/PIs, together with an advisory committee composed of basi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2021 Category: Research Source Type: funding
Cardiovascular Biorepository for Type 1 Diabetes (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites a single cooperative agreement application to establish a biorepository of human cardiovascular (CV) tissue and an infrastructure for discovery and mechanistic research to increase our knowledge of the CV complications of type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of death and morbidity for individuals with T1D, but no T1D-specific therapy exists to prevent or treat this complication of diabetes because of challenges from inadequate preclinical models, decades-l...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 4, 2021 Category: Research Source Type: funding
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-21-003 from the NIH Guide for Grants and Contracts. This FOA invites applications for a Biostatistics Research Center to participate in a clinical consortium to better understand youth-onset type 2 diabetes. A separate FOA (RFA-DK-21-002) invites Clinical Centers to recruit a cohort of early pubertal youth at risk for developing type 2 diabetes and study them through puberty. The ultimate goals of this consortium will be to 1) develop more precise prediction of which individuals are truly at risk for developing youth-onset T2D and identify determinants of progression from prediabetes to T2D so...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
